The year’s midpoint is still a good time to reflect on performance thus far and what may lie ahead. What sectors are strong and which are poised to bounce back in the second half?
Financial Advisor IQ’s webcast “Opportunities and Challenges for the Remainder of 2017,” sponsored by OppenheimerFunds, addresses these questions and more. Panelists reveal key market and macro risks, their most compelling sectors and regions, the role the Fed is likely to play in the markets, and the effects of outside forces – including the White House and Capitol Hill.
This video webcast was pre-recorded and features two financial advisors whose firms were recently ranked in the FT 300 list of top RIAs: Jennifer Ellison, a Principal at Bingham, Osborn & Scarborough, and Brian Flynn, a Vice President at Dynasty Private Wealth. They were joined by Brian Levitt, a Senior Investment Strategist at OppenheimerFunds. The panel was moderated by Financial Advisor IQ Managing Editor Bruce Love.
The video will become available to watch on Tuesday, July 18, 2017, at 11:00am ET. Register now and we’ll send you a calendar reminder for this event.
Follow @OppFunds for more news and commentary.
Please note that by registering for this webcast you are consenting to have Financial Advisor IQ share your information with OppenheimerFunds, who may subsequently contact you.
This material is provided for general and educational purposes only, is not intended to provide legal or tax advice, and is not for use to avoid penalties that may be imposed under U.S. federal tax laws. OppenheimerFunds is not undertaking to provide impartial investment advice or to provide advice in a fiduciary capacity. Contact your attorney or other advisor regarding your specific legal, investment or tax situation.
Mutual funds and exchange traded funds are subject to market risk and volatility. Shares may gain or lose value.
These views represent the opinions of OppenheimerFunds, Inc. and are not intended as investment advice or to predict or depict the performance of any investment. These views are as of the publication date, and are subject to change based on subsequent developments.